2018
DOI: 10.1021/acschembio.8b00155
|View full text |Cite
|
Sign up to set email alerts
|

Chemical Control over T-Cell Activation in Vivo Using Deprotection of trans-Cyclooctene-Modified Epitopes

Abstract: Activation of a cytotoxic T-cell is a complex multistep process, and tools to study the molecular events and their dynamics that result in T-cell activation in situ and in vivo are scarce. Here, we report the design and use of conditional epitopes for time-controlled T-cell activation in vivo. We show that trans-cyclooctene-protected SIINFEKL (with the lysine amine masked) is unable to elicit the T-cell response characteristic for the free SIINFEKL epitope. Epitope uncaging by means of an inverse-electron dema… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
39
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 44 publications
(39 citation statements)
references
References 55 publications
0
39
0
Order By: Relevance
“…[6] The IEDDA/pyridazine elimination reaction, [7] a" click-to-release" reaction in which an allylic substituent on trans-cyclooctene( 2-TCO,a xial (E)-cyclooct-2-en-1-ol) is eliminated upon rearrangement of the pyridazinei ntermediate, has proven particularly favorable in this regard and it showse xcellent biocompatibility [8] and low toxicity. [9] In vivo applicationsi nclude the chemical control of drug release, [10] control over T-cell activation, [11] releaseo f drugs from hydrogels, [12] as well as control over kinase activity in mice. [9] Mechanistic insights into this reactionh ave provided ap athway to improvingt his ligation/elimination reaction.…”
Section: Introductionmentioning
confidence: 99%
“…[6] The IEDDA/pyridazine elimination reaction, [7] a" click-to-release" reaction in which an allylic substituent on trans-cyclooctene( 2-TCO,a xial (E)-cyclooct-2-en-1-ol) is eliminated upon rearrangement of the pyridazinei ntermediate, has proven particularly favorable in this regard and it showse xcellent biocompatibility [8] and low toxicity. [9] In vivo applicationsi nclude the chemical control of drug release, [10] control over T-cell activation, [11] releaseo f drugs from hydrogels, [12] as well as control over kinase activity in mice. [9] Mechanistic insights into this reactionh ave provided ap athway to improvingt his ligation/elimination reaction.…”
Section: Introductionmentioning
confidence: 99%
“…[86] The faster kinetics of the trans-cyclooctene/tetrazine chemistry relative to the Staudinger reaction enabled the control of T-cell activationi n vivo by using epitopes with trans-cyclooctene-caged lysines. [87] Wang et al further used dissociative bioorthogonal chemistry to manipulate the chargeonc ell-surface glycans to controlc ell clustering. [24] These studies showedt he broad applicability of the chemical unmasking of protein residues.…”
Section: Using Dissociative Chemistry To Control the Activityo F Protmentioning
confidence: 99%
“…The azide group prevented recognition of the peptide by cognate T cells; after Staudinger reduction to the lysine, the antigen peptide could be detected by T cells, and this activated them in vitro . The faster kinetics of the trans ‐cyclooctene/tetrazine chemistry relative to the Staudinger reaction enabled the control of T‐cell activation in vivo by using epitopes with trans ‐cyclooctene‐caged lysines . Wang et al.…”
Section: Applications Of Dissociative Bioorthogonal Reactions In the mentioning
confidence: 99%
“…Since our original description of the flow photoisomerization protocol, it has been employed by a number of groups for trans ‐cyclooctene synthesis with applications that include radiochemistry, cellular imaging, drug delivery and materials science . There have also been a number of modifications to the flow procedure that have been introduced.…”
Section: Figurementioning
confidence: 99%